BioMarin Pharmaceutical, Inc. (BMRN)
65.04
-1.66
(-2.50%)
USD |
NASDAQ |
Aug 24, 16:00
65.04
0.00 (0.00%)
After-Hours: 19:58
BioMarin Pharmaceutical Price : 65.04 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 67.55 | 68.34 | 66.52 | 66.70 | 1.594M |
| Aug 20, 2026 | 68.11 | 68.75 | 67.56 | 67.68 | 1.276M |
| Aug 19, 2026 | 68.17 | 69.62 | 67.75 | 69.33 | 1.977M |
| Aug 18, 2026 | 67.21 | 68.26 | 66.84 | 66.99 | 1.942M |
| Aug 17, 2026 | 67.00 | 67.63 | 66.21 | 66.64 | 2.238M |
| Aug 14, 2026 | 68.53 | 68.53 | 67.12 | 67.36 | 1.413M |
| Aug 13, 2026 | 70.35 | 70.35 | 68.36 | 68.53 | 2.317M |
| Aug 12, 2026 | 68.71 | 70.98 | 68.29 | 70.24 | 2.841M |
| Aug 11, 2026 | 69.50 | 70.62 | 68.71 | 69.55 | 3.966M |
| Aug 10, 2026 | 64.22 | 69.27 | 63.37 | 68.88 | 5.037M |
| Aug 07, 2026 | 64.82 | 64.92 | 62.20 | 63.81 | 4.365M |
| Aug 06, 2026 | 60.46 | 61.67 | 58.89 | 61.46 | 3.453M |
| Aug 05, 2026 | 61.46 | 61.48 | 59.78 | 59.91 | 1.686M |
| Aug 04, 2026 | 59.89 | 60.83 | 59.33 | 60.72 | 1.239M |
| Aug 03, 2026 | 60.43 | 60.69 | 59.75 | 60.00 | 1.847M |
| Jul 31, 2026 | 60.38 | 60.80 | 58.92 | 60.02 | 2.377M |
| Jul 30, 2026 | 60.60 | 60.84 | 59.72 | 60.58 | 1.224M |
| Jul 29, 2026 | 62.07 | 62.30 | 61.19 | 61.37 | 1.805M |
| Jul 28, 2026 | 61.00 | 63.05 | 60.92 | 62.07 | 1.942M |
| Jul 27, 2026 | 59.89 | 60.99 | 59.32 | 60.27 | 1.627M |
| Jul 24, 2026 | 59.24 | 59.35 | 58.61 | 59.33 | 1.938M |
| Jul 23, 2026 | 57.99 | 59.07 | 57.42 | 58.87 | 2.504M |
| Jul 22, 2026 | 59.50 | 59.98 | 58.30 | 58.40 | 1.428M |
| Jul 21, 2026 | 58.96 | 59.71 | 58.26 | 59.21 | 1.622M |
| Jul 20, 2026 | 59.59 | 59.94 | 59.00 | 59.11 | 1.178M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 127.99 |
| Alnylam Pharmaceuticals, Inc. | 236.06 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
| Ionis Pharmaceuticals, Inc. | 62.03 |
| Regeneron Pharmaceuticals, Inc. | 828.72 |
Price Related Metrics
| PE Ratio | 175.34 |
| PS Ratio | 3.652 |
| Price to Book Value | 1.991 |
| Price to Free Cash Flow | 17.41 |
| Earnings Yield | 0.57% |
| Market Cap | 12.59B |
| Operating PE Ratio | 19.74 |
| Normalized PE Ratio | 33.01 |